Vaxcyte, Inc. (PCVX)
NASDAQ:PCVX
Holding PCVX?
Track your performance easily

Vaxcyte (PCVX) Financial Statements

215 Followers

Vaxcyte Financial Overview

Vaxcyte's market cap is currently ―. The company's EPS TTM is $-4.755; its P/E ratio is -24.55; Vaxcyte is scheduled to report earnings on November 4, 2024, and the estimated EPS forecast is $-1.12. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -128.70M$ -114.35M$ -180.80M$ -92.66M$ -68.34M
EBITDA$ -114.23M$ -111.25M$ -177.85M$ -104.76M$ -77.78M
Net Income Common Stockholders$ -129.10M$ -95.02M$ -180.80M$ -92.66M$ -68.34M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.45B$ 1.49B$ 1.08B$ 1.27B$ 1.29B
Total Assets$ 2.09B$ 2.09B$ 1.41B$ 1.50B$ 1.50B
Total Debt$ 25.58M$ 27.42M$ 29.22M$ 13.81M$ 15.21M
Net Debt$ -1.43B$ -1.46B$ -1.05B$ -1.25B$ -1.27B
Total Liabilities$ 101.14M$ 107.32M$ 167.45M$ 93.34M$ 69.44M
Stockholders Equity$ 1.99B$ 1.98B$ 1.24B$ 1.40B$ 1.43B
Cash Flow-
Free Cash Flow$ -129.18M$ -164.80M$ -185.88M$ -64.89M$ -60.60M
Operating Cash Flow$ -121.39M$ -159.12M$ -128.81M$ -57.55M$ -62.74M
Investing Cash Flow$ -80.41M$ -451.07M$ -13.93M$ 22.28M$ -333.56M
Financing Cash Flow$ 110.37M$ 818.20M$ 2.73M$ 48.55M$ 546.97M
Currency in USD

Vaxcyte Earnings and Revenue History

Vaxcyte Debt to Assets

Vaxcyte Cash Flow

Vaxcyte Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis